TECH - Bio-Techne Corp Stock Analysis
Bio-Techne Corp (TECH) is a publicly traded company listed on the NASD. It operates in the Biotechnology industry, part of the broader Healthcare sector. The company has a market capitalization of 9.25B, generates annual revenue of 1.22B, and reports net income of 77.95M. As of the latest data, the stock is trading at 59.38 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (0.54%) is modest, often associated with growth-oriented companies. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Buy (4.09), indicating current market sentiment. Institutional ownership is reported at 104.94%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -20.20%, trading within a 52-week range of 46.01 - 79.28.
TECH - Bio-Techne Corp
59.38
Analyst Consensus
Buy 4.09
TECH – Analyst Rating Summary
- Strong Buy: 7
- Buy: 11
- Hold: 5
- Sell: 0
- Strong Sell: 0
- Total Analysts: 23
| Index: | S&P 500 | P/E: | 121.38 | EPS (ttm): | 0.49 | Insider Own: | 1.19% | Shs Outstand: | 155.75M | Perf Week: | 3.43% |
| Market Cap: | 9.25B | Forward P/E: | 26.81 | EPS next Y: | 2.22 | Insider Trans: | -1.87% | Shs Float: | 153.95M | Perf Month: | -3.60% |
| Income(ttm): | 77.95M | PEG: | 11.77 | EPS next Q: | 0.44 | Inst Own: | 104.94% | Short Float: | 4.93% | Perf Quarter: | 11.43% |
| Revenue(ttm): | 1.22B | P/S: | 7.60 | EPS this Y: | 3.52% | Inst Trans: | 1.17% | Short Ratio: | 3.33 | Perf Half Y: | 20.81% |
| Book/sh: | 12.62 | P/B: | 4.70 | EPS next Y: | 11.46% | ROA: | 2.96% | Short Interest: | 7.59M | Perf Year: | -20.20% |
| Cash/sh: | 0.93 | P/C: | 63.83 | EPS next 5Y: | 10.31% | ROE: | 3.80% | 52W Range: | 46.01 - 79.28 | Perf YTD: | -17.56% |
| Dividend Est.: | 0.32 (0.54%) | P/FCF: | 41.29 | EPS past 3/5Y: | -34.80% -20.58% | ROIC: | 3.32% | 52W High: | 79.28 -25.10% | Beta: | 1.46 |
| Dividend TTM: | 0.32 (0.54%) | Quick Ratio: | 2.81 | Sales past 3/5Y: | 3.33% 10.55% | Gross Margin: | 66.79% | 52W Low: | 46.01 29.06% | Perf 5Y: | -21.92% |
| Dividend Ex-Date: | Nov 17, 2025 | Current Ratio: | 4.22 | EPS Y/Y TTM: | -48.17% | Oper. Margin: | 21.89% | RSI (14): | 47.61 | Volatility: | 3.43% 3.76% |
| Employees: | 3100 | Debt/Eq: | 0.20 | Sales Y/Y TTM: | 3.85% | Profit Margin: | 6.41% | Recom: | 1.56 | Target Price: | 69.17 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.19 | EPS Q/Q: | 17.12% | Payout: | 69.67% | Rel Volume: | 0.87 | Prev Close: | 60.75 |
| Sales Surprise: | -1.63% | EPS Surprise: | -0.33% | Sales Q/Q: | -1.00% | Earnings: | Nov 05 BMO | Avg Volume: | 2.28M | Price: | 59.38 |
| SMA20: | -3.57% | SMA50: | 2.00% | SMA200: | 6.03% | Undervalued: 16.49% | Volume: | 1,969,052 | Change: | -2.26% | |
Graham Classic formula value: 12.81
(P/E=8 * 1g) Min value: 8.06
(current P/E * 2g) Max value: 62.48
Average value: 27.78
About Bio-Techne Corp
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.